[HTML][HTML] Toward regeneration of the heart: bioengineering strategies for immunomodulation
A Ferrini, MM Stevens, S Sattler… - Frontiers in …, 2019 - frontiersin.org
Myocardial Infarction (MI) is the most common cardiovascular disease. An average-sized MI
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …
[HTML][HTML] Macrophages: First guards in the prevention of cardiovascular diseases
MI Nasser, S Zhu, H Huang, M Zhao, B Wang, H Ping… - Life sciences, 2020 - Elsevier
Cardiovascular diseases (CVD) remain one of the leading causes of mortality worldwide,
especially in developing countries. It is widely known that severe inflammation can lead to …
especially in developing countries. It is widely known that severe inflammation can lead to …
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
fibrosis and inflammation in tissue pathophysiology
Mammalian tissues react to damage by activating the highly specialized response of wound
healing. Acute inflammation is the first and fastest mechanism activated in the damaged …
healing. Acute inflammation is the first and fastest mechanism activated in the damaged …
[HTML][HTML] Lymphocytic subsets play distinct roles in heart diseases
J Wang, Y Duan, JPG Sluijter, J Xiao - Theranostics, 2019 - ncbi.nlm.nih.gov
Heart diseases are one of the leading causes of death for humans in the world. Increasing
evidence has shown that myocardial injury induced innate and adaptive immune responses …
evidence has shown that myocardial injury induced innate and adaptive immune responses …
Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction Scar
D Martínez-Falguera, J Aranyó, A Teis… - Circulation …, 2024 - Am Heart Assoc
BACKGROUND: Sacubitril/valsartan (Sac/Val) is superior to angiotensin-converting enzyme
inhibitors in reducing the risk of heart failure hospitalization and cardiovascular death, but its …
inhibitors in reducing the risk of heart failure hospitalization and cardiovascular death, but its …
[HTML][HTML] Takotsubo syndrome: latest addition to the expanding family of immune-mediated diseases?
broken heart syndrome, is a severe and acute heart failure syndrome that often resolves
spontaneously but can also be associated with significant mortality. TTS predominantly …
spontaneously but can also be associated with significant mortality. TTS predominantly …
Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer's Disease
DUSP4 is a member of the DUSP (dual-specificity phosphatase) subfamily that is selective
to the mitogen-activated protein kinases (MAPK) and has been implicated in a range of …
to the mitogen-activated protein kinases (MAPK) and has been implicated in a range of …
Takotsubo syndrome and rheumatic diseases—a critical systematic review
Since its description in 1990, Takotsubo syndrome (TTS), an acute cardiac condition
triggered by physical or emotional stress, has been believed to be related to catecholamine …
triggered by physical or emotional stress, has been believed to be related to catecholamine …
Impact of cardiac rehabilitation programs on left ventricular remodeling after acute myocardial infarction: Study Protocol Clinical Trial (SPIRIT Compliant)
Conclusion: In conclusion, REHAB will be the first trial that will elucidate the impact of early
mobilization in the first period after AMI, as a first step of a complex cardiac rehabilitation …
mobilization in the first period after AMI, as a first step of a complex cardiac rehabilitation …